Labcorp Holdings Inc
LH: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| %<> | LOCK|LT@Q | LOCK|%#>>Nb&# |
Labcorp Earnings: Strong Organic Growth Supported by Robust Healthcare Utilization
Labcorp reported third-quarter top-line growth of 7%, supported by strong organic diagnostic base business growth of 6%. Operating margin remains mildly hampered by the integration of Invitae (genetic testing), but this should ease in the second half of 2025.
